Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Clinitech Laboratory Ltd submitted a quarterly certificate from its Registrar and Transfer Agent (Bigshare Services Pvt. Ltd.) under SEBI's Regulation 74(5) for the quarter ended June 30, 2025. The RTA confirmed that the regulation is not applicable to the company since all of its shares are already held in dematerialised (demat) form. No requests from any shareholder for rematerialisation of shares were received during the quarter. The disclosure was signed by Chairman and Managing Director Jagdish Umakant Nayak on July 14, 2025.
This is a routine compliance filing with no impact on the company's financials, operations, or share price. It simply confirms that all Clinitech Laboratory shares are held in demat form, which is standard for listed companies.